Is there any real reason a far sighted Pharma couldn’t do a deal with PAR prior to 2x2 dose validation.
Cant they just do the deal on the proviso 2x2 gets approved with a walk away clause if 2x2 dose not approved by the FDA etc.
Is there any real reason a far sighted Pharma couldn’t do a deal...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 26.5¢ | 25.5¢ | $61.58K | 238.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 62473 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.0¢ |
Change
-0.005 ( 1.07 %) |
||||
| Open | High | Low | Volume | ||
| 26.5¢ | 26.5¢ | 25.5¢ | 105880 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| PAR (ASX) Chart |